Nature Communications (Aug 2024)
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
- Atish Mukherji,
- Frank Jühling,
- Yogy Simanjuntak,
- Emilie Crouchet,
- Fabio Del Zompo,
- Yuji Teraoka,
- Alexandre Haller,
- Philippe Baltzinger,
- Soumith Paritala,
- Fahmida Rasha,
- Naoto Fujiwara,
- Cloé Gadenne,
- Nevena Slovic,
- Marine A. Oudot,
- Sarah C. Durand,
- Clara Ponsolles,
- Catherine Schuster,
- Xiaodong Zhuang,
- Jacinta Holmes,
- Ming-Lun Yeh,
- Hiromi Abe-Chayama,
- Mathias Heikenwälder,
- Angelo Sangiovanni,
- Massimo Iavarone,
- Massimo Colombo,
- Steven K. H. Foung,
- Jane A. McKeating,
- Irwin Davidson,
- Ming-Lung Yu,
- Raymond T. Chung,
- Yujin Hoshida,
- Kazuaki Chayama,
- Joachim Lupberger,
- Thomas F. Baumert
Affiliations
- Atish Mukherji
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Frank Jühling
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Yogy Simanjuntak
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Emilie Crouchet
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Fabio Del Zompo
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Yuji Teraoka
- Department of Gastroenterology, National Hospital Organization Kure Medical Center
- Alexandre Haller
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/University of Strasbourg
- Philippe Baltzinger
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/University of Strasbourg
- Soumith Paritala
- Department of Internal Medicine, University of Texas Southwestern Medical Center
- Fahmida Rasha
- Department of Internal Medicine, University of Texas Southwestern Medical Center
- Naoto Fujiwara
- Department of Internal Medicine, University of Texas Southwestern Medical Center
- Cloé Gadenne
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Nevena Slovic
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Marine A. Oudot
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Sarah C. Durand
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Clara Ponsolles
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Catherine Schuster
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Xiaodong Zhuang
- Nuffield Department of Medicine, University of Oxford
- Jacinta Holmes
- University of Melbourne, St Vincent’s Hospital
- Ming-Lun Yeh
- Hepatobiliary Division, Department of Internal Medicine, School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University
- Hiromi Abe-Chayama
- Center for Medical Specialist Graduate Education and Research, Hiroshima University
- Mathias Heikenwälder
- Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ)
- Angelo Sangiovanni
- Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
- Massimo Iavarone
- Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
- Massimo Colombo
- EASL International Liver Foundation
- Steven K. H. Foung
- Department of Pathology, Stanford University School of Medicine
- Jane A. McKeating
- Nuffield Department of Medicine, University of Oxford
- Irwin Davidson
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/University of Strasbourg
- Ming-Lung Yu
- Hepatobiliary Division, Department of Internal Medicine, School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University
- Raymond T. Chung
- Gastrointestinal Division, Hepatology and Liver Center, Massachusetts General Hospital
- Yujin Hoshida
- Department of Internal Medicine, University of Texas Southwestern Medical Center
- Kazuaki Chayama
- RIKEN Center for Integrative Medical Sciences
- Joachim Lupberger
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- Thomas F. Baumert
- University of Strasbourg, Institute of Translational Medicine and Liver Diseases (ITM)
- DOI
- https://doi.org/10.1038/s41467-024-51698-8
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 14
Abstract
Abstract Chronic liver disease and cancer are global health challenges. The role of the circadian clock as a regulator of liver physiology and disease is well established in rodents, however, the identity and epigenetic regulation of rhythmically expressed genes in human disease is less well studied. Here we unravel the rhythmic transcriptome and epigenome of human hepatocytes using male human liver chimeric mice. We identify a large number of rhythmically expressed protein coding genes in human hepatocytes of male chimeric mice, which includes key transcription factors, chromatin modifiers, and critical enzymes. We show that hepatitis C virus (HCV) infection, a major cause of liver disease and cancer, perturbs the transcriptome by altering the rhythmicity of the expression of more than 1000 genes, and affects the epigenome, leading to an activation of critical pathways mediating metabolic alterations, fibrosis, and cancer. HCV-perturbed rhythmic pathways remain dysregulated in patients with advanced liver disease. Collectively, these data support a role for virus-induced perturbation of the hepatic rhythmic transcriptome and pathways in cancer development and may provide opportunities for cancer prevention and biomarkers to predict HCC risk.